Skip to main content
. 2018 Nov-Dec;39(6):e55–e63. doi: 10.2500/aap.2018.39.4160

Table 3.

Summary of adverse reactions after intravenous administration of LOCM in cohort 1 and cohort 2

graphic file with name zsn00618-4160-t03.jpg

graphic file with name zsn00618-4160-t03a.jpg

graphic file with name zsn00618-4160-t03b.jpg

graphic file with name zsn00618-4160-t03c.jpg

LOCM = Low-osmolality iodinated contrast media; CM = contrast media; CPR = cardiopulmonary resuscitation.

*There were 18,628 Iopromide 370 injections in cohort 1 and 82,989 injections in cohort 2.

#There was 28,570 Iopamidol 370 injections in cohort and 97,633 injections in cohort 2.

§Patients had more than one symptom after a single injection of CM.

¶There were 18,591 iohexol 350 injections in cohort 1 and 8606 injections in cohort 2.

‡There were 4657 iopromide 300 injections in cohort 1 and 14,645 injections in cohort 2.